Structural Formula (Bupropion Hydrochloride Xl 1)
Bupropion Hydrochloride Tablet, Film Coated, Extended Release
Product Images NDC 63187-766
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Bupropion Hydrochloride (NDC 63187-766). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
63187-766-30 (Bupropion Hydrochloride Xl 2)
This is a medication guide and label for Bupropion HCI 150mg (Once Daily) Extended-Release tablets. The tablets are round, white to off-white, film-coated and bi-convex in shape, with "WPI" over "3331" printed in black ink. Each tablet contains Bupropion Hydrochloride, USP 150 mg. The medication guide should be provided separately to each patient. The tablets should not be used in combination with ZYBANs or other medicines that contain bupropion hydrochloride. The medicine is packaged in #30 XL tablets, containing lot number #00000, and expires on 00/00/00. The product is made by Actavis Laboratories FL Inc., Fort Lauderdale, FL, and is relabeled by Proficient Rx LP, Thousand Oaks, CA. The GTIN is 0036318766306. Store the medicine at 20°C-28°C (66°-77°F) and keep it out of reach of children.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
